US equities |
MU $989.04 ▼-3.88% META $742.96 ▲+3.38% NVDA $226.32 ▼-1.29% SNDK $1,487.33 ▼-5.97% SPCX $163.42 ▲+0.52% MSFT $541.15 ▲+1.14% AMD $594.24 ▼-2.28% AAPL $340.97 ▲+1.29%
FinancialContent

Tectonic Therapeutic, Inc. - Common Stock (NQ:TECX)

22.35 -0.98 (-4.20%)
Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tectonic Therapeutic, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
TECTONIC THERAPEUTIC INC (NASDAQ:TECX) Q1 Loss Wider Than Expected, Pipeline Progress Provides Key Catalyst ↗
Via Chartmill
Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate ↗
Via Stocktwits
News headline image
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Participate in March Investor Conferences
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
From Tectonic Therapeutic
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill
Top movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
Tectonic Therapeutic to Participate in December Investor Conferences
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Tectonic Therapeutic Stock Soared 30% After-Hours Today ↗
TX45, Tectonic’s experimental Fc-relaxin fusion protein, showed strong improvements in heart and lung function with no serious safety issues in patients with heart failure-related pulmonary... 
Via Stocktwits
News headline image
What's going on in today's after hours session ↗
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
From Tectonic Therapeutic
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Here are the top movers in Tuesday's session. ↗
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session. ↗
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Tuesday's pre-market session: top gainers and losers ↗
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
< Previous 1 2 3 Next >